Cyclic di-AMP and its role in DNA repair and drug resistance in Mycobacterium
Author Information
Author(s): Mudgal Sudhanshu, Goyal Nisha, Kasi Manikandan, Saginela Rahul, Singhal Anusha, Nandi Soumyadeep, Mahmud A K M Firoj, Muniyappa Kalappa, Sinha Krishna Murari, Bahar Ivet
Primary Institution: Amity Institute of Biotechnology, Amity University Haryana
Hypothesis
How does cyclic di-AMP regulate genome stability and drug resistance in Mycobacterium?
Conclusion
Cyclic di-AMP is crucial for maintaining genomic stability and modulating drug resistance in Mycobacterium by regulating DNA repair pathways.
Supporting Evidence
- Cyclic di-AMP binds to mycobacterial RecA proteins and inhibits its DNA strand exchange activity.
- Cells lacking c-di-AMP show increased DNA recombination and higher mutation rates.
- The absence of c-di-AMP enhances drug resistance in Mycobacterium smegmatis.
- Cyclic di-AMP regulates the SOS response by inhibiting RecA-mediated self-cleavage of LexA repressor.
- Deletion of disA leads to hyper-recombinogenic RecA activity.
- Complementation with wild-type disA restores normal levels of DNA repair.
- c-di-AMP is essential for the viability of various bacterial species.
Takeaway
Cyclic di-AMP helps bacteria fix their DNA and fight off drugs, and without it, they can become more resistant to treatment.
Methodology
The study used genetic assays to analyze DNA repair pathways in Mycobacterium smegmatis, focusing on the effects of cyclic di-AMP on RecA-mediated and RecA-independent homologous recombination.
Limitations
The precise mechanisms of how cyclic di-AMP affects RecA-independent pathways remain unclear.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website